220 related articles for article (PubMed ID: 30407737)
1. Exploring macrophage cell therapy on Diabetic Kidney Disease.
Guiteras R; Sola A; Flaquer M; Manonelles A; Hotter G; Cruzado JM
J Cell Mol Med; 2019 Feb; 23(2):841-851. PubMed ID: 30407737
[TBL] [Abstract][Full Text] [Related]
2. Macrophage Overexpressing NGAL Ameliorated Kidney Fibrosis in the UUO Mice Model.
Guiteras R; Sola A; Flaquer M; Hotter G; Torras J; Grinyó JM; Cruzado JM
Cell Physiol Biochem; 2017; 42(5):1945-1960. PubMed ID: 28793288
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
4. Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1.
Lee HW; Khan SQ; Khaliqdina S; Altintas MM; Grahammer F; Zhao JL; Koh KH; Tardi NJ; Faridi MH; Geraghty T; Cimbaluk DJ; Susztak K; Moita LF; Baltimore D; Tharaux PL; Huber TB; Kretzler M; Bitzer M; Reiser J; Gupta V
J Biol Chem; 2017 Jan; 292(2):732-747. PubMed ID: 27913625
[TBL] [Abstract][Full Text] [Related]
5. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
6. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.
Loretelli C; Rocchio F; D'Addio F; Ben Nasr M; Castillo-Leon E; Dellepiane S; Vergani A; Abdelsalam A; Assi E; Maestroni A; Usuelli V; Bassi R; Pastore I; Yang J; El Essawy B; Elased KM; Fadini GP; Ippolito E; Seelam AJ; Pezzolesi M; Corradi D; Zuccotti GV; Gallieni M; Allegretti M; Niewczas MA; Fiorina P
Metabolism; 2021 Aug; 121():154804. PubMed ID: 34097917
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes.
Lei Y; Devarapu SK; Motrapu M; Cohen CD; Lindenmeyer MT; Moll S; Kumar SV; Anders HJ
Front Immunol; 2019; 10():1223. PubMed ID: 31191559
[TBL] [Abstract][Full Text] [Related]
8. Suppressed recruitment of alternatively activated macrophages reduces TGF-β1 and impairs wound healing in streptozotocin-induced diabetic mice.
Okizaki S; Ito Y; Hosono K; Oba K; Ohkubo H; Amano H; Shichiri M; Majima M
Biomed Pharmacother; 2015 Mar; 70():317-25. PubMed ID: 25677561
[TBL] [Abstract][Full Text] [Related]
9. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
10. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes.
Flaquer M; Franquesa M; Vidal A; Bolaños N; Torras J; Lloberas N; Herrero-Fresneda I; Grinyó JM; Cruzado JM
Diabetologia; 2012 Jul; 55(7):2059-68. PubMed ID: 22460762
[TBL] [Abstract][Full Text] [Related]
13. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
[TBL] [Abstract][Full Text] [Related]
14. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
[TBL] [Abstract][Full Text] [Related]
15. The Role of Bone Marrow Cells in the Phenotypic Changes Associated with Diabetic Nephropathy.
Yang G; Cheng Q; Liu S; Zhao J
PLoS One; 2015; 10(9):e0137245. PubMed ID: 26340671
[TBL] [Abstract][Full Text] [Related]
16. Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.
Dessapt-Baradez C; Woolf AS; White KE; Pan J; Huang JL; Hayward AA; Price KL; Kolatsi-Joannou M; Locatelli M; Diennet M; Webster Z; Smillie SJ; Nair V; Kretzler M; Cohen CD; Long DA; Gnudi L
J Am Soc Nephrol; 2014 Jan; 25(1):33-42. PubMed ID: 24009238
[TBL] [Abstract][Full Text] [Related]
17. Jixuepaidu Tang-1 inhibits epithelial-mesenchymal transition and alleviates renal damage in DN mice through suppressing long non-coding RNA LOC498759.
Jin J; Zhang Z; Chen J; Liu Y; Chen Q; Wang Q
Cell Cycle; 2019 Nov; 18(22):3125-3136. PubMed ID: 31564202
[TBL] [Abstract][Full Text] [Related]
18. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
19. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
[TBL] [Abstract][Full Text] [Related]
20. Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice.
Takahashi N; Yoshida H; Kimura H; Kamiyama K; Kurose T; Sugimoto H; Imura T; Yokoi S; Mikami D; Kasuno K; Kurosawa H; Hirayama Y; Naiki H; Hara M; Iwano M
Nephrol Dial Transplant; 2020 Oct; 35(10):1678-1688. PubMed ID: 32596728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
